Abstract
Health anxiety, while not a diagnosis, refers to a set of symptoms characterized by preoccupied worry with having or developing a serious medical illness. An individual presenting with interfering and distressing symptoms of health anxiety may receive a DSM-5 diagnosis of illness anxiety disorder (previously known as hypochondriasis) or somatic symptom disorder, based on the amount of physical complaints they have. Unfortunately, health anxiety is often initially misdiagnosed or undiagnosed due to an individual’s belief that their symptoms are solely physical. Health anxiety is costly to society due to lost work productivity and increased use of medical services. However, health anxiety can be successfully treated within a cognitive-behavioral framework. Intervention techniques include psychoeducation, exposure and response prevention, stress management, and mindfulness processes. Health anxiety symptoms have also shown improvement through pharmacological interventions. Chapter highlights include the definition of health anxiety, various treatment approaches and their efficacies, considerations in light of comorbid physical conditions, and case examples. Ultimately, we conclude that health anxiety, while challenging to diagnose and build trust for treatment in the beginning stages, can be treated effectively within a cognitive-behavioral framework through targeting dysfunctional beliefs about illness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramowitz, J. S., Deacon, B. J., & Valentiner, D. P. (2007). The short health anxiety inventory: Psychometric properties and construct validity in a non-clinical sample. Cognitive Therapy and Research, 31(6), 871–883.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
Andersson, G., Cuijpers, P., Carlbring, P., Riper, H., & Hedman, E. (2014). Internet-based vs. face-to-face cognitive behaviour therapy for psychiatric and somatic disorders: A systematic review and meta-analysis. World Psychiatry, 13, 288–295.
Asmundson, G. J. G., Taylor, S., & Cox, B. J. (Eds.). (2001). Health anxiety: Clinical and research perspectives on hypochondriasis and related disorders. New York: Wiley.
Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006). Using self-report assessment methods to explore facets of mindfulness. Assessment, 13, 27–45.
Barsky, A. J., & Ahern, D. K. (2004). Cognitive behavior therapy for hypochondriasis: A randomized controlled trial. JAMA: Journal of the American Medical Association, 291(12), 1464–1470.
Barsky, A. J., Wyshak, G., Latham, K. S., & Klerman, G. L. (1991). The relationship between hypochondriasis and medical illness. Archives of Internal Medicine, 151(1), 84–88.
Bennett, P., Patterson, K., & Noble, S. (2016). Predicting post-traumatic stress and health anxiety following a venous thrombotic embolism. Journal of Health Psychology, 21(5), 863–871.
Bernstein, I. C., Callahan, W. A., & Jaranson, J. M. (1975). Lobotomy in private practice: Long-term follow-up. Archives of General Psychiatry, 32(8), 1041–1047.
Christoph, M., Christoph, A., Dannemann, S., Poitz, D., Pfluecke, C., Strasser, R. H., … Ibrahim, K. (2014). Mental symptoms in patients with cardiac symptoms and normal coronary arteries. Open Heart, 1(1), e000093.
Cooper, K., Gregory, J. D., Walker, I., Lambe, S., & Salkovskis, P. M. (2017). Cognitive behaviour therapy for health anxiety: A systematic review and meta-analysis. Behavioural and Cognitive Psychotherapy, 45(2), 110–123.
Dinkel, A., Kremsreiter, K., Marten-Mittag, B., & Lahmann, C. (2014). Comorbidity of fear of progression and anxiety disorders in cancer patients. General Hospital Psychiatry, 36(6), 613–619.
Eilenberg, T., Kronstrand, L., Fink, P., & Frostholm, L. (2013). Acceptance and commitment group therapy for health anxiety—Results from a pilot study. Journal of Anxiety Disorders, 27(5), 461–468.
Fallon, B. A., Ahern, D. K., Pavlicova, M., Slavov, I., Skritskya, N., & Barksy, A. J. (2017). A randomized controlled trial of medication and cognitive-behavioral therapy for psychochondriasis. American Journal of Psychiatry, 174, 756–764.
Fallon, B. A., Petkova, E., Skritskaya, N., Sanchez-Lacay, A., Schneier, F., Vermes, D., … Liebowitz, M. R. (2008). A double-masked, placebo-controlled study, of fluoxetine for hypochondriasis. Journal of Clinical Psychopharmacology, 28(6), 638–645.
Fazil, M., Akram, M., & Kapoor, P. (2013). General hypochondriasis in diabetes mellitus type- II (DM-II): Implications for clinicians. Global Journal of Medicine and Public Health, 2(3), 1–11.
Feuerstein, M., Bruns, G. L., Pollman, C., & Todd, B. L. (2010). Management of unexplained symptoms in survivors of cancer. Journal of Oncology Practice, 6(6), 308–311.
Fietta, P., & Manganelli, P. (2007). Fibromyalgia and psychiatric disorders. Acta Bio Medica Atenei Parmensis, 78(2), 88–95.
Fink, P., Hansen, M. S., & Oxhoj, M. L. (2004). The prevalence of somatoform disorders among internal medical inpatients. Journal of Psychosomatic Research, 56(4), 413–418.
Fishbain, D. A., Lewis, J. E., Gao, J., Cole, B., & Steele Rosomoff, R. (2009). Is chronic pain associated with somatization/hypochondriasis? An evidence-based structured review. Pain Practice, 9(6), 449–467.
Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99(1), 20–35.
Fujishiro, H., Iritani, S., Sekiguchi, H., Habuchi, C., Torii, Y., Matsunaga, S., … Fujita, K. (2016). Hypochondriasis as an early manifestation of dementia with Lewy bodies: An autopsied case report. Psychogeriatrics, 16(2), 139–144.
Gomborone, J., Dewsnap, P., Libby, G., & Farthing, M. (1995). Abnormal illness attitudes in patients with irritable bowel syndrome. Journal of Psychosomatic Research, 39(2), 227–230.
Greeven, A., van Balkom, A. M., Visser, S., Merkelbach, J. W., van Rood, Y. R., van Dyck, R., … Spinhoven, P. (2007). Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: A randomized controlled trial. The American Journal of Psychiatry, 164(1), 91–99.
Hedman, E., Axelsson, E., Görling, A., Ritzman, C., Ronnheden, M., El Alaoui, S., … Ljótsson, B. (2014). Internet-delivered exposure-based cognitive–behavioural therapy and behavioural stress management for severe health anxiety: Randomised controlled trial. The British Journal of Psychiatry, 205(4), 307–314.
Hedman, E., Lindefors, N., Andersson, G., Andersson, E., Lekander, M., Rück, C., & Ljótsson, B. (2013). Predictors of outcome in Internet-based cognitive behavior therapy for severe health anxiety. Behaviour Research and Therapy, 51(10), 711–717.
Hedman, E., Ljótsson, B., Andersson, E., Rück, C., Andersson, G., & Lindefors, N. (2010). Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: An open trial. Cognitive Behaviour Therapy, 39(4), 239–250.
Hedman, E., Ljótsson, B., Axelsson, E., Andersson, G., Rück, C., & Andersson, E. (2017). Health anxiety in obsessive compulsive disorder and obsessive compulsive symptoms in severe health anxiety: An investigation of symptom profiles. Journal of Anxiety Disorders, 4, 580–586.
Janzen Claude, J. A., Hadjistavropoulos, H. D., & Friesen, L. (2014). Exploration of health anxiety among individuals with diabetes: Prevalence and implications. Journal of Health Psychology, 19(2), 312–322.
Jones, S. L., Hadjistavropoulos, H. D., & Sherry, S. B. (2012). Health anxiety in women with early-stage breast cancer: What is the relationship to social support? Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement, 44(2), 108.
Korkmaz, H., Korkmaz, S., Yildiz, S., Gündoğan, B., & Atmaca, M. (2017). Determination of health anxiety, anxiety, and somatosensory amplification levels in individuals with normal coronary angiography. Psychiatry Research, 252, 114–117.
Lebel, S., Tomei, C., Feldstain, A., Beattie, S., & McCallum, M. (2013). Does fear of cancer recurrence predict cancer survivors’ health care use? Supportive Care in Cancer, 21(3), 901–906.
Miles, A., & Wardle, J. (2006). Adverse psychological outcomes in colorectal cancer screening: Does health anxiety play a role? Behaviour Research and Therapy, 44(8), 1117–1127.
Olatunji, B. O., Deacon, B. J., & Abramowitz, J. S. (2009). Is hypochondriasis an anxiety disorder? The British Journal of Psychiatry, 194(6), 481–482.
Olatunji, B. O., Etzel, E. N., Tomarken, A. J., Ciesielski, B. G., & Deacon, B. (2011). The effects of safety behaviors on health anxiety: An experimental investigation. Behaviour Research and Therapy, 49(11), 719–728.
Olatunji, B. O., Kauffman, B. Y., Meltzer, S., Davis, M. L., Smits, J. J., & Powers, M. B. (2014). Cognitive-behavioral therapy for hypochondriasis/health anxiety: A meta-analysis of treatment outcome and moderators. Behaviour Research and Therapy, 58, 65–74.
Sarkar, S., Sautier, L., Schilling, G., Bokemeyer, C., Koch, U., & Mehnert, A. (2015). Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients. Journal of Cancer Survivorship, 9(4), 567–575.
Shafran, R., Clark, D. M., Fairburn, C. G., Arntz, A., Barlow, D. H., Ehlers, A., … Salkovskis, P. M. (2009). Mind the gap: Improving the dissemination of CBT. Behaviour Research and Therapy, 47(11), 902–909.
Sørensen, P., Birket-Smith, M., Wattar, U., Buemann, I., & Salkovskis, P. (2011). A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychological Medicine, 41(2), 431–441.
Strang, S., Ekberg-Jansson, A., & Henoch, I. (2014). Experience of anxiety among patients with severe COPD: A qualitative, in-depth interview study. Palliative and Supportive Care, 12(6), 465–472.
Tang, N. K., Salkovskis, P. M., Hodges, A., Soong, E., Hanna, M. H., & Hester, J. (2009). Chronic pain syndrome associated with health anxiety: A qualitative thematic comparison between pain patients with high and low health anxiety. British Journal of Clinical Psychology, 48(1), 1–20.
Taylor, S. (2004). Understanding and treating health anxiety: A cognitive-behavioral approach. Cognitive and Behavioral Practice, 11(1), 112–123.
Taylor, S., & Asmundson, G. J. G. (2004). Treating health anxiety: A cognitive-behavioral approach. New York: The Guilford Press.
Taylor, S., Asmundson, G. J. G., & Coons, M. J. (2005). Current directions in the treatment of hypochondriasis. Journal of Cognitive Psychotherapy, 19(3), 285–304.
Thakur, E. R., Sansgiry, S., Petersen, N. J., Stanley, M., Kunik, M. E., Naik, A. D., & Cully, J. A. (2018). Cognitive and perceptual factors, not disease severity, are linked with anxiety in COPD: Results from a cross-sectional study. International Journal of Behavioral Medicine, 25(1), 74–84.
Thewes, B., Brebach, R., Dzidowska, M., Rhodes, P., Sharpe, L., & Butow, P. (2014). Current approaches to managing fear of cancer recurrence; A descriptive survey of psychosocial and clinical health professionals. Psychooncology, 23(4), 390–396.
Thomson, A. B., & Page, L. A. (2007). Psychotherapies for hypochondriasis. Cochrane Database of Systematic Reviews, 4, CD006520.
Trumbo, C. W., McComas, K. A., & Kannaovakun, P. (2007). Cancer anxiety and the perception of risk in alarmed communities. Risk Analysis, 27(2), 337–350.
Tyrer, P., Tyrer, H., Morriss, R., Crawford, M., Cooper, S., Yang, M., … Barrett, B. (2017). Clinical and cost-effectiveness of adapted cognitive behaviour therapy for non-cardiac chest pain: A multicentre, randomised controlled trial. Open Heart, 4(1), e000582.
von Leupoldt, A., & Janssens, T. (2016). Could targeting disease specific fear and anxiety improve COPD outcomes? Expert Review of Respiratory Medicine, 10(8), 835–837.
Weck, F., Neng, J. M., Göller, K., & Müller-Marbach, A. M. (2014). Previous experiences with illness and traumatic experiences: A specific risk factor for hypochondriasis? Psychosomatics, 55(4), 362–371.
Weck, F., Neng, J. B., Schwind, J., & Höfling, V. (2015). Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial. Journal of Anxiety Disorders, 34, 1–7.
Weck, F., Richtberg, S., Jakob, M., Neng, J. B., & Höfling, V. (2015). Therapist competence and therapeutic alliance are important in the treatment of health anxiety (hypochondriasis). Psychiatry Research, 228(1), 53–58.
Wells, A. (1997). Cognitive therapy of anxiety disorders: A practice manual and conceptual guide. Chichester, UK: Wiley.
Willgoss, T. G., & Yohannes, A. M. (2013). Anxiety disorders in patients with COPD: A systematic review. Respiratory Care, 58(5), 858–866.
Zwart, J. A., Dyb, G., Hagen, K., Ødegård, K. J., Dahl, A. A., Bovim, G., & Stovner, L. J. (2003). Depression and anxiety disorders associated with headache frequency. The Nord-Trøndelag Health Study. European Journal of Neurology, 10(2), 147–152.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rutter, L., Nota, J.A., Yusufov, M., Björgvinsson, T. (2018). Health Anxiety: A Cognitive-Behavioral Framework. In: Charis, C., Panayiotou, G. (eds) Somatoform and Other Psychosomatic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-89360-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-89360-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89359-4
Online ISBN: 978-3-319-89360-0
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)